Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
The public health summit in Addis Ababa will bring together policymakers, scientists, healthcare leaders, and global partners
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
More than 120 speakers and 5,000 delegates are expected to attend
Subscribe To Our Newsletter & Stay Updated